Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Lijo Simpson"'
Publikováno v:
Journal of Clinical Oncology. 39:212-212
212 Background: The 2006 ASCO and the ESMO consensus statement on quality cancer care defined the delivery of multimodality treatment by a multidisciplinary team of appropriately skilled health professionals as an essential component of quality cance
Publikováno v:
Journal of Clinical Oncology. 39:e13561-e13561
e13561 Background: Cancer centers in the US are required to discuss a minimum of 15% analytic cases and prospective presentation (minimum 80%) in the multidisciplinary case conference (tumor board, MDCC), per the Commission on Cancer accrediting stan
Publikováno v:
Journal of registry management. 44(4)
Autor:
Anju Mathew, Lijo Simpson
Publikováno v:
Journal of Clinical Oncology. 36:e18779-e18779
e18779Background: Multidisciplinary tumor conferences provide an opportunity to enhance patient care. The engagement of multiple disciplines is thought to improve outcomes for cancer patients. To a...
Autor:
Hartzell V. Schaff, Shaji Kumar, Timothy J. Moynihan, Lijo Simpson, Scott H. Okuno, Jan C. Buckner, Luis F. Porrata
Publikováno v:
Cancer. 112:2440-2446
BACKGROUND. Primary cardiac sarcomas are uncommon. The authors undertook to review the Mayo Clinic's experience with primary cardiac sarcomas consisting of 34 patients seen over a 32-year period. METHODS. The patient database at the Mayo Clinic was s
Autor:
Mala Vohra, Lijo Simpson, Ramamoorthy Sundaresan, Carey August, Imran Ali, Derin Cougar, John N. Sheagren
Publikováno v:
Gastrointestinal Endoscopy. 61:926-928
mucosa induced by hypertonic enemas. Dis Colon Rectum 1978;21: 227-36. 12. Meyer CT, Brand M, DeLuca VA, Spiro HM. Hydrogen peroxide colitis: a report of three patients. J Clin Gastroenterol 1981;3:31-5. 13. Guth PH, Paulsen G, Nagata H. Histologic a
Publikováno v:
The American Journal of Medicine. 117:210-212
Publikováno v:
Journal of Clinical Oncology. 22:196-198
Autor:
Lijo Simpson, Morie Gertz
Publikováno v:
Myeloma Therapy ISBN: 9781934115824
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::950d7357b8e105476c15d76a709becb3
https://doi.org/10.1007/978-1-59745-564-0_32
https://doi.org/10.1007/978-1-59745-564-0_32
Autor:
Kay M. Ristow, Ivana N. Micallef, Thomas M. Habermann, David J. Inwards, Patrick B. Johnston, Stephen M. Ansell, Svetomir N. Markovic, Luis F. Porrata, Joseph P. Colgan, Thomas E. Witzig, Lijo Simpson
Publikováno v:
Leukemialymphoma. 48(7)
DHAP (dexamethasone, cytosine arabinoside and cis-platinum) is a commonly used regimen for relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The optimal treatment for patients who do not respond to DHAP, but are still potential candidates